AITOPAI热报
USGrantIn forceModel providersDeployersHealth

ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

ARPA-H投资6200万美元开发AI治疗心力衰竭
ARPA-H·Published 2026-09-09·Checked by 管理员 on 2026-09-15

ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure.

Source ↗Remind meUS · All

What it means for you

  • ARPA-H is investing in an AI heart failure treatment program;
  • The AI bots will receive FDA authorization;
  • This project is a significant innovation in the medical field.

    • What to do

    EveryoneMonitor the progress of ARPA-H's AI heart failure treatment program
    EngineeringAssess the potential of AI technology in this field
    ComplianceFollow the FDA's authorization process for AI bots

    Key dates

    2026-09-09Published

    Source documents

    Source ↗

    Coverage

    Stories in the feed
    Editorial summary, not legal advice; dates and status follow the original document. · Report a correction